While these transcriptional profiling data cannot dissect the impact of intracellular (ISGylation-associated) vs. extracellular cytokine-like attributes on ISG15-related outcomes in melanoma patients, they are consistent with an immunoregulatory role for high expression levels of ISG15 in the TME. This evidence concerns the gene ISG15 and melanoma.